Model-Assisted Designs for Identifying the Optimal Biological Dose
Haitao Pan () and
Ying Yuan ()
Additional contact information
Haitao Pan: St. Jude Children’s Research Hospital, Department of Biostatistics
Ying Yuan: The University of Texas MD Anderson Cancer Center, Department of Biostatistics
Chapter Chapter 5 in Bayesian Adaptive Design for Immunotherapy and Targeted Therapy, 2023, pp 71-88 from Springer
Abstract:
Abstract Compared to the model-assisted designs introduced in Chapter 4, model-based designs are complicated statistically and computationally, making them more challenging to implement in practice. This chapter introduces two model-assisted phase I/II designs, BOIN12 and U-BOIN, to find the optimal biological dose (OBD). These two designs simultaneously consider toxicity and efficacy, and use the utility to quantify the risk-benefit tradeoff. Based on the accrued toxicity and efficacy data, the designs adaptively assign patients according to the estimated utility. As model-assisted designs, BOIN12 and U-BOIN have the advantages of being simple to implement and meanwhile yielding competitive performances. Conducting the trial does not require complicated model estimation. The decision of dose transition can be easily made by looking up the pre-generated decision table. Examples and software are provided to illustrate BOIN12 and U-BOIN.
Date: 2023
References: Add references at CitEc
Citations:
There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-981-19-8176-0_5
Ordering information: This item can be ordered from
http://www.springer.com/9789811981760
DOI: 10.1007/978-981-19-8176-0_5
Access Statistics for this chapter
More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().